Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hogan

Showing results (481-490 of 484) with videos related to

Pageof 49
Sort By:
You have reached the last page of results.This site can display upto 484 results.
Clinical Journal of the American Society of Nephrology : CJASN|December 15, 2015
Complete Remission in the Nephrotic Syndrome Study NetworkDebbie S Gipson, Jonathan P Troost, Richard A Lafayette, et al.
Kidney International|November 28, 2022
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosisLaura H Mariani, Sean Eddy, Fadhl M AlAkwaa, et al.
Journal of Translational Medicine|June 23, 2023
Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)Filippo Pinto E Vairo, Jennifer L Kemppainen, Carolyn R Rohrer Vitek, et al.
Journal of Translational Medicine|April 30, 2024
Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)Filippo Pinto E Vairo, Jennifer L Kemppainen, Carolyn R Rohrer Vitek, et al.
Pageof 49

Showing results (481-490 of 484) with videos related to

Sort By:
Pageof 49
You have reached the last page of results.This site can display upto 484 results.
Clinical Journal of the American Society of Nephrology : CJASN|December 15, 2015
Complete Remission in the Nephrotic Syndrome Study NetworkDebbie S Gipson, Jonathan P Troost, Richard A Lafayette, et al.
Kidney International|November 28, 2022
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosisLaura H Mariani, Sean Eddy, Fadhl M AlAkwaa, et al.
Journal of Translational Medicine|June 23, 2023
Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)Filippo Pinto E Vairo, Jennifer L Kemppainen, Carolyn R Rohrer Vitek, et al.
Journal of Translational Medicine|April 30, 2024
Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)Filippo Pinto E Vairo, Jennifer L Kemppainen, Carolyn R Rohrer Vitek, et al.
Pageof 49